申请人:Pfizer Inc
公开号:US07071337B2
公开(公告)日:2006-07-04
The invention relates to compounds of the formula 1
and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1, R2, R3, and R4 are as defined herein. The invention also relates to methods of treating abnormal cell growth, such as cancer, in mammals by administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
本发明涉及到公式1的化合物及其药学上可接受的盐、前药和溶剂化物,其中R1、R2、R3和R4的定义如本文所述。本发明还涉及通过给予公式1的化合物治疗哺乳动物的异常细胞增长,如癌症的方法,以及包含公式1的化合物的用于治疗此类疾病的制药组合物。本发明还涉及制备公式1的化合物的方法。